OCVA

Recent NHANES analyses show that aligning meals with circadian rhythms, especially eating last meals early, reduces epigenetic age acceleration, with…

The FDA’s updated guidelines on cellular reprogramming, highlighted by Life Biosciences’ ER-100 trial for eye conditions, signal a pivotal shift…

Recent research reveals APOE4 increases hippocampal neuron excitability before Alzheimer’s symptoms, offering early detection via interictal spikes and potential interventions…

uPAR-targeted CAR T cell therapy shows promising results in solid tumors, with recent clinical trials and FDA designations advancing cancer…

Muscle-generated exerkines in extracellular vesicles are crucial for exercise-induced health, with new research suggesting therapies for sarcopenia and metabolic diseases…

Analyzing recent rapamycin clinical trials for anti-aging, focusing on optimal dosing, safety, and the shift from off-label use to evidence-based…

Recent studies show aging clocks integrating clinical and microbiome data can predict biological age, enabling personalized anti-aging interventions through tailored…

Recent studies highlight how probiotics and fecal microbiota transplantation reduce neuroinflammation and improve cognitive function in neurodegenerative diseases, offering new…